Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 3/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.32 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.31 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.31 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA7 | P43166 | 1/20 | 0.30 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25182554 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TDP1LMNACYP3A4TSHR | |
| SCHEMBL8639706 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TDP1LMNACYP3A4TSHR | |
| SCHEMBL3094381 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TDP1LMNACYP3A4TSHR | |
| SCHEMBL25185567 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TDP1LMNACYP3A4TSHR | |
| SCHEMBL6761849 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TDP1LMNACYP3A4TSHR | |
| SCHEMBL25185557 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TDP1LMNACYP3A4TSHR | |
| SCHEMBL5682734 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TDP1LMNACYP3A4TSHR | |
| SCHEMBL199452 | 0.98 | ALDH1A1 (0.41) | ALDH1A1TDP1LMNACYP3A4TSHR | |
| SCHEMBL5984758 | 0.93 | ALDH1A1 (0.39) | ALDH1A1TDP1LMNACYP3A4TSHR | |
| SCHEMBL5985735 | 0.93 | ALDH1A1 (0.39) | ALDH1A1TDP1LMNACYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105518053-B | aliphatic polycarbonate compositions and methods | 诺沃梅尔公司 | 2017-07-21 | — | — | CN | claimed |
| CN-118201905-A | Cationic lipid | 武田药品工业株式会社 | 2024-06-14 | — | — | CN | disclosed |
| WO-2023163463-A1 | RESIN COMPOSITION AND DISPLAY DEVICE COMPRISING SAME | 삼성디스플레이주식회사 | 2023-08-31 | — | — | WO | disclosed |
| WO-2023085299-A1 | CATIONIC LIPID | 武田薬品工業株式会社 | 2023-05-19 | — | — | WO | disclosed |
| CN-111684325-B | Cured liquid crystal layer, method for producing same, optical film, polarizing plate, and display device | 日本瑞翁株式会社 | 2022-08-19 | — | — | CN | disclosed |
| EP-3039055-B1 | ALIPHATIC POLYCARBONATE-BASED SURFACE ACTIVE AGENTS | SASOL CHEMICALS USA LLC (US) | 2020-04-15 | — | — | EP | disclosed |
| US-10011758-B2 | Aliphatic polycarbonate-based surface active agents | SASOL CHEMICALS (USA) LLC (US) | 2018-07-03 | — | — | US | disclosed |
| US-20160200962-A1 | Aliphatic Polycarbonate-Based Surface Active Agents | SASOL CHEMICALS (USA) LLC | 2016-07-14 | — | — | US | disclosed |
| EP-3039055-A1 | ALIPHATIC POLYCARBONATE-BASED SURFACE ACTIVE AGENTS | Sasol Chemicals (USA) LLC (US) | 2016-07-06 | — | — | EP | disclosed |
| WO-2015031348-A1 | ALIPHATIC POLYCARBONATE-BASED SURFACE ACTIVE AGENTS | SASOL CHEMICALS (USA) LLC (US) | 2015-03-05 | — | — | WO | disclosed |
| EP-2029573-B1 | DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS | BASF SE (DE) | 2011-10-26 | — | — | EP | disclosed |
| US-20110042651-A1 | LIQUID CRYSTALLINE RYLENE TETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF | BASF SE (DE) | 2011-02-24 | — | — | US | disclosed |
| WO-2010111822-A1 | OLIGOCONDENSED PERYLENE BISIMIDES | BASF SE (DE) | 2010-10-07 | — | — | WO | disclosed |
| WO-2010112452-A1 | OLIGOCONDENSED PERYLENE BISIMIDES | BASF SE (DE) | 2010-10-07 | — | — | WO | disclosed |
| US-20100048904-A1 | DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS | BASF AKTIENGESELLSCHAFT (DE) | 2010-02-25 | — | — | US | disclosed |
| EP-2029573-A1 | DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS | BASF SE (DE) | 2009-03-04 | — | — | EP | disclosed |
| EP-2008319-A2 | LIQUID CRYSTALLINE RYLENE TETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF | BASF SE (DE) | 2008-12-31 | — | — | EP | disclosed |
| WO-2007138051-A1 | DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS | BASF SE (DE) | 2007-12-06 | — | — | WO | disclosed |
| WO-2007116001-A2 | LIQUID CRYSTALLINE RYLENE TETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF | BASF SE (DE) | 2007-10-18 | — | — | WO | disclosed |
| EP-1843407-A1 | Liquid crystalline rylenetetracarboxylic acid derivatives and their use | BASF AKTIENGESELLSCHAFT (DE) | 2007-10-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048904-A1 | DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS | TDO2, C9, CYP3A43 | ALDH1A1 627/4885TDP1 3791/4885LMNA 1646/4885 |
| US-20110042651-A1 | LIQUID CRYSTALLINE RYLENE TETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF | TPR, ROR1, CA3 | ALDH1A1 4792/4885TDP1 3204/4885LMNA 2934/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.